RGENRepligen Corporation
123.43USD-0.88%Mkt Cap: 6.98B USDP/E: 137.48Last update: 2026-06-01

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fib…

Indicators:|

Key Statistics

Company
Market Cap6.98B USD
Enterprise Value6.90B USD
Revenue (TTM)763.34M USD
Gross Profit386.25M USD
Net Income (TTM)48.89M USD
Revenue/Share13.56 USD
Last Price123.43 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.0K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS7599161095
Valuation
P/E (Trailing)137.48
P/E (Forward)48.56
PEG1.94
EV/EBITDA51.38
EV/Revenue9.03
P/S9.16
P/B3.32
EPS (TTM)0.91
EPS (Forward)2.55
52W Range
100.9930% of range175.77
52W High175.77 USD
52W Low100.99 USD
Profitability
Gross Margin52.32%
Oper. Margin8.90%
EBITDA Margin17.59%
Profit Margin6.62%
ROE2.32%
ROA1.66%
Growth
Revenue Growth14.80%
Earnings Growth47.90%
Cash Flow & Leverage
Operating CF117.42M USD
CapEx (TTM)25.73M USD
FCF Margin9.00%
FCF Yield0.98%
Net Debt-96.91M USD
Net Debt/EBITDA-0.72
Balance Sheet
Debt/Equity0.33
Current Ratio9.20
Quick Ratio7.45
Book Value/Sh37.33 USD
Cash/Share13.91 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)178.74 USD
Target Range142.00 USD220.00 USD
# Analysts19
Ownership
Shares Out.56.41M
Float53.36M
Insiders5.25%
Institutions119.66%
Short Interest
Short Ratio4.4d
Short % Float10.13%
Short % Out.10.10%
Shares Short5.70M
Short (prev mo.)5.49M
Technical
SMA 50117.86 (+4.7%)
SMA 200137.80 (-10.4%)
Beta1.09
S&P 52W Chg27.70%
Avg Vol (30d)1.21M
Avg Vol (10d)1.46M
Technical Indicators
RSI (14)58.8
MACD-0.3242
MACD Signal-2.0491
MACD Hist.+1.7249
BB Upper131.25 USD
BB Middle115.52 USD
BB Lower99.79 USD
BB Width27.23%
ATR (14)6.382 USD
Vol Ratio (20d)0.27x